Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Clinical Trial, Phase II

Clinical Trial

Randomized Controlled Trial

Multicenter Study

Clinical Trial, Phase III

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2012

2007

2006

2003

2002

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Vomiting, Anticipatory""[mesh_terms]

5 Results

Searching titles within these results

Phase II study of a weekly 8-hour 5-fluorouracil and leucovorin infusion for patients with advanced colorectal cancer: dose adjusted according to its toxicity.

T S Yang, K C Hsu, H M Wang, Y C Lin

Japanese journal of clinical oncology 2002;31(12):610-5

Full Text

Abstract

Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer.

Fikri Icli, Hakan Akbulut, Gungor Utkan, Bülent Yalcin, Dilek Dincol, Abdurrahman Isikdogan, Ahmet Demirkazik, Handan Onur, Filiz Cay, Abdullah Büyükcelik

Journal of surgical oncology 2007;95(6):507-12

Full Text

Abstract

Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients.

Julie L Ryan, Charles E Heckler, Joseph A Roscoe, Shaker R Dakhil, Jeffrey Kirshner, Patrick J Flynn, Jane T Hickok, Gary R Morrow

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(7):1479-89

Free Full Text

Abstract

Multicenter phase II trial of weekly paclitaxel for advanced or metastatic breast cancer: the Saitama Breast Cancer Clinical Study Group (SBCCSG-01).

Kazuhiko Sato, Kenichi Inoue, Tsuyoshi Saito, Toshihiro Kai, Hiroyoshi Mihara, Katsuhiko Okubo, Junichi Koh, Hidetaka Mochizuki, Toshio Tabei

Japanese journal of clinical oncology 2003;33(8):371-6

Full Text

Abstract

Phase II randomized trial of tri-weekly versus days 1 and 8 weekly docetaxel as a second-line treatment of advanced non-small cell lung cancer.

Chun-Liang Lai, Chun-Ming Tsai, Chao-Hua Chiu, Gwo-Shu Wang, Wei-Juin Su, Yuh-Min Chen, Reury-Perng Perng

Japanese journal of clinical oncology 2006;35(12):700-6

Full Text

Abstract

Results: 1 – 5 / 5

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Vomiting, Anticipatory""[mesh_terms]

Phase II study of a weekly 8-hour 5-fluorouracil and leucovorin infusion for patients with advanced colorectal cancer: dose adjusted according to its toxicity.

Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer.

Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients.

Multicenter phase II trial of weekly paclitaxel for advanced or metastatic breast cancer: the Saitama Breast Cancer Clinical Study Group (SBCCSG-01).

Phase II randomized trial of tri-weekly versus days 1 and 8 weekly docetaxel as a second-line treatment of advanced non-small cell lung cancer.

Results for
""Vomiting, Anticipatory""[mesh_terms]